Loading company…
Xinchuan Biotechnology develops immune cell therapy drugs for several cancers.
Xinchuan Biotechnology develops immune cell therapy drugs using iPSC-CAR-NK and organoid high-throughput screening technologies. Its product pipelines target lung, liver, and colorectal cancers and B-lymphoma. Founded in 2021, the company is based in Beijing, China.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in